Hugo sits in DEPLOY's verified-but-opaque surgical tier: it has real regulatory clearance, but Medtronic discloses no installed-base count. It is the middle of the spectrum between Intuitive's transparent scale and J&J's pre-market research.
✔
Hugo is CE-marked in Europe (urology and gynecology, October 2021) and US FDA-cleared for urology (December 2025: prostatectomy, nephrectomy, cystectomy).
Price
No reviewed price is on record. We do not treat unverified analyst estimates as pricing data. There is no consumer price. The Hugo RAS is enterprise B2B surgical equipment sold to hospitals on per-system contracts, so DEPLOY records zero price points.
Availability
Internal use only
The Hugo RAS is sold to hospitals, not consumers. Medtronic does not disclose a Hugo installed-base count, so DEPLOY records honest absence rather than an invented number.
Real-world status
The Hugo RAS is a modular, multi-port teleoperated robotic-assisted-surgery system and the main commercial competitor to Intuitive's da Vinci. It is CE-marked in Europe (urology and gynecology, October 2021) and US FDA-cleared for urology only (December 2025: prostatectomy, nephrectomy, cystectomy); US general-surgery and gynecology indications are planned but not yet cleared. It is teleoperated with no shipped intraoperative AI. DEPLOY places Hugo in the verified-but-opaque tier: real regulatory clearance, but no public system-count disclosure, between Intuitive's transparent verified-at-scale and J&J's pre-market research.
⊘
Medtronic does not disclose a Hugo installed-base count. DEPLOY records that absence rather than an invented number; aggregator figures for this entity are not treated as verified.
⚠
US clearance is urology-only. General-surgery and gynecology indications are planned but not yet cleared, so do not read Hugo as broadly cleared in the US. It is also teleoperated, with no shipped intraoperative AI.
For urology only (December 2025: prostatectomy, nephrectomy, cystectomy)🟢verified. It is CE-marked in Europe (2021); US general-surgery and gynecology are not yet cleared⊘absence.
How many Hugo systems are installed?
Medtronic does not disclose a count⊘absence, so DEPLOY records honest absence rather than an invented or aggregator number.
Can I buy a Medtronic Hugo?
Not as a consumer⊘absence. It is enterprise B2B surgical equipment sold to hospitals; there is no consumer price.
How does Hugo compare to da Vinci?
Hugo is da Vinci's main commercial competitor🟢verified, but where Intuitive transparently reports 11,395 installed systems, Medtronic discloses no Hugo count, and US clearance is urology-only.
Does the Hugo have AI?
It is teleoperated with no shipped intraoperative AI🟢verified; a surgeon controls the system.
Pricing and availability are tagged verified or claimed against primary sources. Manufacturer targets are reported as targets, not prices you can pay today.